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Abstract
Background: The trophoblast lineage arises as the first differentiation event during embryogenesis. Trophoblast
giant cells are one of several end-stage products of trophoblast cell differentiation in rodents. These cells are
located at the maternal-fetal interface and are capable of invasive and endocrine functions, which are necessary for
successful pregnancy. Rcho-1 trophoblast stem cells can be effectively used as a model for investigating
trophoblast cell differentiation. In this report, we evaluated the role of the phosphatidylinositol 3-kinase (PI3K)
signaling pathway in the regulation of trophoblast cell differentiation. Transcript profiles from trophoblast stem
cells, differentiated trophoblast cells, and differentiated trophoblast cells following disruption of PI3K signaling were
generated and characterized.
Results: Prominent changes in gene expression accompanied the differentiation of trophoblast stem cells. PI3K
modulated the expression of a subset of trophoblast cell differentiation-dependent genes. Among the PI3K-
responsive genes were those encoding proteins contributing to the invasive and endocrine phenotypes of
trophoblast giant cells.
Conclusions: Genes have been identified with differential expression patterns associated with trophoblast stem
cells and trophoblast cell differentiation; a subset of these genes are regulated by PI3K signaling, including those
impacting the differentiated trophoblast giant cell phenotype.
Background
Hemochorial placental development is a complex pro-
cess involving multiple signaling pathways. Effectively
two placental compartments are established. One com-
partment contains trophoblast cells specialized for inter-
actions with the maternal environment, while the other
contains trophoblast cells directed toward the bidirec-
tional transport of nutrients and wastes between the
mother and the fetus. Trophoblast cells of the rat and
mouse have the capacity to differentiate along a multi-
lineage pathway. Cell lineages directed toward the
maternal environment, include trophoblast giant cells,
spongiotrophoblast, glycogen cells, and invasive tropho-
blast cells; whereas syncytial trophoblast regulate mater-
nal-fetal nutrient and waste delivery [1-3]. Each lineage
possesses specialized functions necessary for a normal
pregnancy.
Trophoblast giant cells are the first trophoblast lineage
to differentiate [4]. Trophoblast giant cells are located at
the maternal-fetal interface and have several functions.
They produce steroid and peptide hormones [1] and
have the ability to invade into the uterine vasculature
[5,6].
The phosphatidylinositol 3-kinase/protein kinase B
(PI3K/AKT), pathway is involved in trophoblast cell
development [7]. Upon differentiation of trophoblast
cells, PI3K is activated leading to the phosphorylation
and constitutive activation of AKT [7]. Inhibition of
PI3K disrupts AKT activation and interferes with tro-
phoblast cell differentiation [7,8]. The predominant iso-
form of AKT in developing trophoblast giant cells is
AKT1 [7,9]. Mice possessing a null mutation at the Akt1
locus exhibit defects in placental development [9]. Their
placentas are smaller and accumulate less glycogen than
wild-type mice.
In this report, we utilize Rcho-1 rat trophoblast stem
cells as an in vitro model to gain a better understanding
of trophoblast cell differentiation. Rcho-1 trophoblast
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any medium, provided the original work is properly cited.cells are remarkable in that they can be maintained in a
stem cell state or induced to differentiate along the tro-
phoblast giant cell lineage [10-13]. This in vitro system
represents an excellent model for investigating regula-
tory pathways controlling trophoblast giant cell differen-
tiation. In order to gain new insights about trophoblast
cell differentiation we performed genome wide screens
for transcripts expressed in trophoblast stem cells, dif-
ferentiating trophoblast cells, and differentiating tropho-
blast cells with disrupted PI3K signaling. Genes selected
for further analyses exhibited high levels of expression,
prominent differences among the experimental groups,
and/or encoded proteins with actions potentially rele-
vant to trophoblast biology. Expression patterns of a
subset of genes identified from the array were verified
by northern analysis and/or quantitative RT-PCR (qRT-
PCR). In vivo placental expression patterns of the
selected genes identified from the gene profiles were
also determined. ‘Trophoblast stem cell-associated’, ‘dif-
ferentiation-associated’,a n d‘PI3K-regulated’ genes were
identified. A subset of the ‘differentiation-associated’
genes is regulated by the PI3K signaling pathway and
may contribute to the trophoblast cell phenotype.
Methods
Reagents and cDNA generation
All reagents were purchased from Sigma-Aldrich (St.
Louis, MO) unless otherwise noted. cDNAs to selected
transcripts were obtained from Invitrogen (Carlsbad,
CA), American Type Culture Collection (ATCC, Rock-
ville, MD), or cloned using TOPO TA cloning kit (Invi-
trogen). Other cDNAs were gifts from the following
investigators: Atp1a1, Dr. Gustavo Blanco, University of
Kansas Medical Center (Kansas City, KS); Cyp11a1,D r .
JoAnne Richards, Baylor College of Medicine (Houston,
TX); Mmp9, Dr. Ruth Muschel, University of Pennsylva-
nia (Philadelphia, PA), and Prl4a1, Dr. Mary Lynn
Duckworth, University of Manitoba (Winnipeg, Manit-
boa, Canada). Additional file 1: Supplemental Table S1
includes information on the source of cDNAs and pri-
mer sequences used for the generation of cDNAs and
for qRT-PCR.
Animals and tissue collection
Holtzman Sprague-Dawley rats were obtained from Har-
lan Laboratories (Indianapolis, IN). Animals were
housed in an environmentally controlled facility with
lights on from 0600-2000 h and were allowed free access
to food and water. Timed pregnancies were generated
by cohabitation of female and male animals. The pre-
sence of a copulatory plug or sperm in the vaginal
smear was designated d0.5 of pregnancy. Rat placental
tissues were collected on gestation d11.5 and d18.5. At
d11.5 of gestation, the placenta contains a mixture of
proliferating and differentiating trophoblast cells, while
at gestation d18.5, the placenta is fully mature and com-
prised of differentiated trophoblast cells. D11.5 tissue
samples contained all trophoblast present within the
placentation site, whereas d18.5 tissue samples were
restricted to the junctional zone. Placentation site dis-
sections were performed as previously described [14].
Tissues for histological analysis were frozen in dry-ice
cooled heptane and stored at -80°C. Tissue samples for
RNA extraction were frozen in liquid nitrogen and
stored at -80°C. The University of Kansas Animal Care
and Use Committee approved protocols for the care and
use of animals.
Maintenance of Rcho-1 trophoblast stem cells
Rcho-1 trophoblast stem cells were maintained at sub-
confluent conditions in Stem Medium [RPMI-1640 cul-
ture medium (Cellgro, Herndon, VA) supplemented
with 20% fetal bovine serum (FBS; Atlanta Biologicals,
Norcross, GA) 50 μM 2-mercaptoethanol, 1 mM sodium
pyruvate (Cellgro), 100 μM penicillin, and 100 U/ml
streptomycin (Cellgro)] as previously reported [13,15].
Differentiation was induced by growing cells to near
confluence in FBS-supplemented culture medium and
then replacing the medium with Differentiation Medium
[NCTC-135 medium (Sigma-Aldrich) supplemented
with 1% horse serum (HS; Atlanta Biologicals), 50 μM
2-mercaptoethanol, 1 mM sodium pyruvate, 10 mM
HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (Fisher, Pittsburgh, PA), 38 mM sodium bicarbo-
nate (Fisher), 100 μM penicillin and 100 U/ml strepto-
mycin (Cellgro)]. High cell density and the absence of
sufficient growth stimulatory factors (removal of FBS)
facilitate trophoblast giant cell formation [12,13]. Tryp-
sin (0.25%)-ethylenediamine tetraacetic acid (EDTA,
0.1% in Hank’s Balanced Salt Solution, Cellgro) was
used to passage the cells. Cells in the stem cell condi-
tion were grown in Stem Medium and collected 24 h
after subculture to restrict the accumulation of sponta-
neously differentiating cells. Cells in the differentiation
condition were grown for eight days in Differentiation
Medium prior to harvesting unless otherwise noted.
RNA samples were extracted using TRIzol (Invitrogen)
according to the manufacturer’s instructions.
Inhibition of PI3K
LY294002 (Calbiochem, La Jolla, CA) was used to inhi-
bit PI3K [16]. For chronic treatment experiments, Rcho-
1 trophoblast stem cells were grown to near confluence
and then shifted to Differentiation Medium containing
vehicle (0.1% final concentration of dimethyl sulfoxide,
DMSO) or Differentiation Medium supplemented with
LY294002 (10 μM). This LY294002 treatment regimen
was based on our earlier report, which effectively
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Cells were harvested after eight days of treatment. For
acute inhibition of PI3K, cells were cultured for 6-12
days in Differentiation Medium and then shifted to Dif-
ferentiation Medium containing vehicle (0.1% DMSO)
or LY294002 (10 μM) for 48 h. Culture medium was
replaced daily.
DNA microarray
Affymetrix 230 2.0 DNA microarray chips (Affymetrix,
Santa Clara, CA) were probed with cDNAs generated
from Rcho-1 trophoblast cells grown under stem or dif-
ferentiation conditions with chronic exposure to
LY294002 or vehicle. Each treatment group was
repeated in triplicate. RNA samples were hybridized to
the Affymetrix 230 2.0 DNA microarray chip using the
GeneChip® Hybridization Oven 640 (Affymetrix). Wash-
ing and staining of hybridized chips were conducted
using the GeneChip® Fluidics Station 450 (Affymetrix).
Chips were scanned using the Affymetrix GeneChip®
Scanner 3000 (Affymetrix) with autoloader by the
KUMC Biotechnology Support Facility. Hybridization
signals were normalized with internal controls using the
Mas5 algorithm in Expression Console (Affymetrix) and
fold change computed. Significant differences were
determined by paired two-tailed Student t-tests. Micro-
array data was processed for functional analysis using
Ingenuity Pathway Analysis (Redwood City, CA).
Expression of genes in Rcho-1 trophoblast stem cells
and mouse trophoblast stem cells was compared using
the “Compare Lists of Genes“ program (http://elegans.
uky.edu/MA/progs/Compare.html; Dr. James Lund, Uni-
versity of Kentucky, personal communication). Only
genes annotated identically by Affymterix in both rat
and mouse chips were included. Mouse trophoblast
stem cell array data were downloaded from the Gene
Expression Omnibus (GEO) database http://www.ncbi.
nlm.nih.gov/geo/. TS 3.5 d0 (GSM325436) was com-
pared to TS 3.5 d6 (GSM325442) [17]. Probe sets
included in the analysis were restricted to those chan-
ging at least 1.5 fold between group comparisons with
signal strengths of ≥ 800 for the maximal value.
Northern blotting
Northern blotting analysis was performed as previously
described [18]. Total RNA (20 μg) was separated in 1%
formaldehyde-agarose gels and transferred to nitrocellu-
lose membranes (Schleicher & Schuell Bioscience,
Keene, NH). cDNA inserts were obtained by enzymatic
digestion and labeled with [
32P] (NEN Life Science Pro-
ducts, Boston, MA) using Prime-it II random primer
labeling kits (Stratagene, La Jolla, CA). See Additional
file 1: Supplemental Table S1 for information on
cDNAs. Probes were incubated with the blots at 42°C
overnight and washed with 2XSSPE/0.1XSDS at 42°C
twice for 25 min and 1XSSPE/0.1XSDS at 50°C for 35
min. Blots were then exposed to x-ray film at -80°C.
Glyceraldehyde-3-phosphate dehydrogenase (Gapdh)
was used to assess RNA integrity and as a loading
control.
qRT-PCR
cDNAs were reverse transcribed (RT) from RNA using
reagents from Promega (Madison, WI) according to the
manufacturer’s instructions. SYBR GREEN PCR Master
Mix (Applied Biosystems, Foster City, CA) was used in
the PCR reaction. Reactions were run using a 7500
Real-Time PCR System (Applied Biosystems). Condi-
tions included an initial holding stage (50°C for 2 min
and 95°C for 10 min) and 40 cycles (95°C for 15 s and
60°C for 1 min) followed by a dissociation stage (95°C
for 15 s, 60°C for 1 min, and then 95°C for 15 s). Pri-
mers are listed in Additional file 1: Supplemental Table
S1. Expression of 18 S ribosomal RNA was used as an
internal control. At least four replicates were run for
each condition. Samples were normalized to the control
sample for each gene. Statistical comparisons of two
means were evaluated with Student’s t-test.
In situ hybridization
mRNAs were localized in placental tissues using nonra-
dioactive in situ hybridization as previously described
[3,19]. Ten μm cryosections were prepared and stored at
-80°C until used. Plasmids containing cDNAs were used
as templates to synthesize sense and antisense digoxi-
genin-labeled riboprobes according to the manufac-
turer’si n s t r u c t i o n s( R o c h eM olecular Biochemicals,
Indianapolis, IN). Information on the cDNAs for probe
generation is presented in Additional file 1: Supplemen-
tal Table S1. Tissue sections were air dried and fixed in
ice cold 4% paraformaldehyde in PBS. Prehybridization,
hybridization, and detection of alkaline phosphatase-
conjugated anti-digoxigenin were performed as pre-
viously reported [3,19]. Images were captured using a
Leica MZFLIII stereomicroscope equipped with a Leica
CCD camera (Leica Microsystems GmbH, Welzlar,
Germany).
Immunocytochemistry
Rcho-1 trophoblast stem cells were cultured on chamber
slides under stem, differentiation, or differentiation con-
ditions with chronic exposure to LY294002. Cells were
fixed in ice-cold 4% paraformaldehyde. Actin filaments
were visualized using rhodamine-conjugated phalloidin
(Molecular Probes, Eugene, OR). Nuclei were stained
with 4,6’-diamidino-2-phenylindole (DAPI, Molecular
Probes). Bright field and fluorescence images were cap-
tured using either Leica MZFLIII stereomicroscope or
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(Leica).
Analysis of DNA content
DNA content was estimated by flow cytometry [20].
Cells were trypsinized and fixed in 70% ethanol and
then stained with propidium iodine and analyzed using
a BDLSRIII flow cytometer (BD Biosciences, San Jose,
CA).
Steroid hormone measurements
Steroid radioimmunoassays (RIAs) were performed as
previously reported [21]. Androstenedione and proges-
terone concentrations were measured in Rcho-1 tropho-
blast cell conditioned medium with
125I-labelled RIA
kits (Diagnostic Products, Los Angeles, CA) and normal-
ized to cellular DNA content. DNA samples were
obtained by lysis of cells with digestion buffer contain-
ing proteinase K. Samples were then incubated at 37°C
overnight and diluted 10X with water. DNA content
was then measured with the PicoGreen® dsDNA Quanti-
tation Kit (Molecular Probes) according to the manufac-
turer’s instructions. Statistical comparisons of two
means were evaluated with Student’s t-test.
Results
Identification of genes associated with trophoblast
differentiation
Phenotypes of trophoblast cells connected to distinct
developmental states were assessed by DNA microarray
analysis. Gene-restricted expression patterns associated
with stem cell and differentiated states were identified
(Fig. 1A). All DNA microarray data presented in this
report are deposited in the Gene Expression Omnibus
(GEO) repository under the GSE21938 accession num-
ber http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE21938.
Trophoblast stem-associated genes
Approximately half of the genes differentially expressed
between the stem cell- and differentiated cell-states
were specific to the stem cell state, termed ‘trophoblast
stem cell-associated’ genes. Additional file 2: Supple-
mental Table S2 shows an abbreviated list of ‘tropho-
blast stem cell-associated’ genes. Genes listed in this
table are those with arbitrary expression signal strengths
≥ 800 in the stem cell condition and displaying a signifi-
cantly higher level of expression in the stem cell state
versus the differentiated state (≥ 1.5 fold; P ≤ 0.05). We
used Ingenuity Pathway Analysis software to investigate
‘trophoblast stem cell-associated’ genes. Of the 1720
probe sets listed in Additional file 2: Supplemental
Table S2, 584 genes were annotated by Ingenuity Path-
way Analysis software. Functions associated with the
annotated ‘trophoblast stem cell-associated’ genes
included cellular growth and proliferation (35%), cell
cycle (32%), and cellular assembly and organization
(15%), (Fig. 1B; Additional file 3: Supplemental Table
S3). Not surprisingly, the analysis indicates that a large
percentage of ‘trophoblast stem cell-associated’ genes
have functions that correlate with the proliferative phe-
notype of these cells.
As u b s e to f‘trophoblast stem cell-associated’ genes
identified from the microarray analysis was further eval-
uated (Table 1). Transcript levels were estimated by
northern analysis or qRT-PCR in Rcho-1 trophoblast
cells from stem and differentiated states. Each of the
genes was expressed at higher levels in the trophoblast
stem cell state (Fig. 2). Approximately half of the ‘tro-
phoblast stem cell-associated’ genes showed elevated
expression in midgestation versus late gestation tropho-
blast tissues (Fig. 2). The validated ‘trophoblast stem
cell-associated’ g e n e se n c o d ep r o t e i n si n v o l v e di nc e l l
cycle regulation (Ccne1, Ccna2, Ccnd3, Klf5, Ect2), inhi-
bition of differentiation (S1pr1, Id1, Id2), inhibition of
placental growth (Phlda2), and protection from cyto-
toxic agents (Mt1a1). Other ‘trophoblast stem cell-asso-
ciated’ genes were previously detected in proliferative
populations of trophoblast (Slc16a3, Mif, Atp1a1). Many
of the ‘trophoblast stem cell-associated’ genes identified
in Rcho-1 cells are also found in mouse trophoblast
stem cells (Fig. 1C, D). Conspicuous among the genes
unique to mouse trophoblast stem cells is Elf5, while
Atp1a1, Id3, Mif, Pgam1,a n dS1pr1 are unique to the
Rcho-1 trophoblast stem cell population (Fig. 1D).
Trophoblast differentiation-associated genes
The second collection of genes exhibiting changes in
mRNA expression is upregulated in association with dif-
ferentiation and referred to as ‘differentiation-associated’
genes (Additional file 4: Supplemental Table S4).
Genes listed in this table are those with arbitrary expres-
sion signal strengths ≥ 800 in the differentiated cell con-
dition and displaying a significantly higher level of
expression in the differentiated cell state versus the
stem cell state (≥ 1.5 fold; P ≤ 0.05). Of the 1585 probe
sets listed in Additional file 4: Supplemental Table S4,
537 genes were annotated by Ingenuity Pathway Analy-
sis software. Functions associated with the annotated
‘differentiation-associated’ genes included cellular
growth and proliferation (45%), cell survival (43%), gene
expression (32%), cellular movement (27%), and lipid
metabolism (6%) (Fig. 1B; Additional file 3: Supplemen-
tal Table S3). Many of the genes associated with the
cellular growth and proliferation classification encode
growth factors, cytokines, and peptide hormones (e.g.
Igf2, Grn, members of the prolactin, PRL, family, etc);
and represent features of the endocrine phenotype of
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and lipid metabolism, include those encoding proteins
contributing to the invasive and steroid hormone produ-
cing phenotypes of trophoblast giant cells.
A sampling of ‘differentiation-associated’ genes iden-
tified from the microarray analysis was further exam-
ined (Table 2). Transcript levels were estimated by
northern analysis or qRT-PCR in Rcho-1 trophoblast
cells from stem and differentiated states. Each of the
genes was expressed at higher levels in the differen-
tiated cell state (Fig. 3). Most of the ‘differentiation-
associated’ genes were detected in placental tissues and
approximately half showed elevated expression in late
gestation versus midgestationt r o p h o b l a s tt i s s u e s( F i g .
3). Several of the validated ‘differentiation-associated’
g e n e s( T a b l e2 ;F i g .3 )h a v eb e e np r e v i o u s l yr e p o r t e d
as upregulated during trophoblast giant cell develop-
ment, while others have not been associated with tro-
phoblast lineages (e.g. Rsp1, Sema6 d, Ceacam10,
Cd47, Maged1, Trib3, Hbp1 and Pik3cb). Functions of
the ‘differentiation-associated’ genes have been con-
nected to the regulation of cell movement and invasion
(Serpine1, Adm, Msn, Maged1, Cited2, Fosl1, Ifg2,
Hbp1, Mmp9, Grn, Cd9), interactions with maternal
immune and vascular systems, (Cgm4, Prl4a1, Cd47,
Ecm1, Ctsd, Faslg, Grn, Cd9, Tfpi), and the endocrine
phenotype of trophoblast giant cells (PRL family and
steroid biosynthesis).
As u b s e to f‘differentiation-associated’ mRNAs highly
expressed in rat placental samples (Fig. 3) was localized
to the placentation site via in situ hybridization (Fig 4).
‘Differentiation-associated’ transcripts were all found in
trophoblast giant cells and in most instances other tro-
phoblast lineages. Ecm1 mRNA is expressed in tropho-
blast giant cells and some progenitor trophoblast cells
on gestation d11.5. Tfpi, Cited2,a n dRsp1 transcripts
were localized to trophoblast giant cells on gestation
d11.5, including those penetrating into the uterine spiral
arterioles. On gestation d18.5, Tfpi, Cited2,a n dRsp1
were also identified in spongiotrophoblast. Cgm4 and
Grn transcripts were expressedi nt r o p h o b l a s tg i a n t
cells, spongiotrophoblast, and invasive trophoblast cells
on gestation d18.5. H19 mRNA was expressed in all tro-
phoblast lineages on gestation d11.5 and d18.5. Fn
mRNA was expressed in all trophoblast lineages on
d18.5.
PI3K signaling and trophoblast differentiation
The PI3K signaling pathway has been implicated in the
regulation of trophoblast differentiation [7,8] and was
further investigated in this report. Initially we examined
the effect of disruption of PI3K during trophoblast dif-
ferentiation on the distribution of actin filaments and
DNA content (Fig. 5). Actin filaments were not signifi-
cantly affected by the PI3K inhibitor treatment regimen
used (LY294002, 10 μM; Fig. 5A). However, inhibition
Figure 1 Analysis of microarray data. A) Scatter graph showing the signal intensity of probe sets. B) Functional analysis of ‘trophoblast stem
cell-associated’ genes and ‘differentiation-associated’ genes using Ingenuity Pathway Analysis software. C) Comparison of ‘trophoblast stem cell-
associated’ genes in Rcho-1 trophoblast stem cells and mouse trophoblast stem cells. D) Examples of ‘trophoblast stem cell-associated’ genes
unique to or shared between Rcho-1 trophoblast stem cells and mouse trophoblast stem cells.
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a significant fraction of cells with increased DNA con-
tent, and thus the generation of giant cells with elevated
ploidy levels (Fig. 5B, C). The findings suggest that PI3K
restricts the formation of trophoblast giant cells with
high ploidy levels (> 32N). Higher concentrations of
PI3K inhibitors interfere with actin filament distribu-
tions and cell survival (data not shown). Phenotypes of
differentiating trophoblast cells treated with the PI3K
inhibitor (LY294002, 10 μM )o rv e h i c l ew e r ea l s o
assessed by DNA microarray analysis. Some genes iden-
tified were negatively regulated and others positively
regulated by PI3K signaling (Fig. 6A).
PI3K signaling: negatively regulated genes
The ‘negatively regulated’ PI3K dependent genes are
diverse in their expression patterns (Additional file 5:
Supplemental Table S5). Some are ‘trophoblast stem
cell-associated’ genes, others are ‘differentiation-asso-
ciated’ genes, while still others were not affected by
differentiation state. Genes listed in Additional file 5:
Supplemental Table S5 are those with arbitrary expres-
sion signal strengths ≥ 800 in the differentiated cell con-
dition and displaying a significantly lower level of
expression in the differentiated cell state versus the dif-
ferentiated cell state treated with the PI3K inhibitor (≥
1.5 fold; P ≤ 0.05). Of the 257 probe sets listed in Addi-
tional file 5: Supplemental Table S5, 99 genes were
annotated by Ingenuity Pathway Analysis software.
Functions associated with the annotated ‘negatively
regulated’ genes included cell survival (45%), cellular
assembly and organization (35%), cellular growth and
proliferation (35%), cellular movement (31%), and lipid
metabolism (16%) (Fig. 6B; Additional file 3: Supple-
mental Table S3). These functions overlap with those
observed for both the ‘trophoblast stem cell associated’
and ‘differentiation-associated’ gene profiles (Fig. 1). Of
the sixteen validated ‘trophoblast stem cell-associated’
genes only Id2 was regulated by PI3K signaling (Fig 6D).
Klf2 and Rhob expression was not affected by
Table 1 Trophoblast stem cell associated genes
Gene name Abbreviation Synonyms Functional Group GenBank
Accession No.
Fold
Change S/
D
Fold Change
D/D+LY
Fatty acid binding protein 3 Fabp3 Fatty acid binding NM_024162 -71.41 -
Pleckstrin homology-like domain, family A,
member 2
Phlda2 Ipl, Tssc3 Placental growth NM_001100521 -48.67 -
Inhibitor of DNA binding 2 Id2 Transcription
regulator
NM_013060 -21.03 3.53
Sphingosine-1-phosphate receptor 1 S1pr1 Edg1, IpB1 Lipid receptor NM_017301 -16.08 -
Cyclin E Ccne1 Ccne Cell cycle regulator NM_001100821 -11.52 -
Metallothionein 1a Mt1a Mt Protection from
oxidative stress
NM_138826 -10.75 -
Ect2 oncogene Ect2 Ras signaling NM_001108547 -10.06 -
Aurora kinase B Aurkb Aim1, Stk12 Kinase NM_053749 -9.67 -
Kruppel-like factor 5 Klf5 IKLF, bteb2 Transcription
regulator
NM_053394 -8.85 -
Inhibitor of DNA binding 1 Id1 Transcription
regulator
NM_012797 -8.64 -
Solute carrier family 16 (monocarboxylic acid
transporters), member 3
Slc16a3 Mct3, Mct4 Transporter NM_030834 -6.57 -
Special AT-rich sequence binding protein 1 Satb1 DNA binding NM_001012129 -6.170 -
Cyclin D3 Ccnd3 Cell cycle regulator NM_012766 -6.40 -
Macrophage migration inhibitory factor Mif GIF, Glif Ligand, chemokine NM_031051 -5.32 -
Cyclin A2 Ccna2 Ccn1, Ccna,
Cyca
Cell cycle regulator NM_053702 -4.49 -
ATPase, Na+/K+ transporting, alpha 1
polypeptide
Atp1a1 Nkaa1b,
Atpa-1
NA+/K+ pump NM_012504 -3.95 -
Phosphoglycerate mutase 1 Pgam1 Pgmut Metabolism NM_053290 -3.03 -
Fatty acid binding protein 5, epidermal Fabp5 C-Fabp, E-
Fabp
Fatty acid binding NM_145878 -1.43 -3.23
S/D: Stem cell state/differentiation cell state ratio
D/D+LY: Differentiation cell state/differentiation cell state + LY294002 treatment
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PI3K (Fig. 6D).
PI3K signaling: positively regulated genes
T h em a j o r i t yo f‘positively regulated’ PI3K dependent
genes are included in the ‘differentiation-associated’ gene
set. Genes listed in Additional file 6: Supplemental Table
S6 are those with arbitrary expression signal strengths ≥
800 in the differentiated cell condition and displaying a
significantly higher level of expression in the differentiated
cell state versus the differentiated cell state treated with
the PI3K inhibitor (≥ 1.5 fold; P ≤ 0.05). Of the 226 probe
sets listed in Additional file 6: Supplemental Table S6,9 0
genes were annotated by Ingenuity Pathway Analysis soft-
ware. Functions associated with the annotated ‘positively
regulated’ genes included cell survival (46%), gene expres-
sion (36%), cellular growth and proliferation (29%), small
molecule biochemistry (27%), cellular development (26%),
cellular movement (24%), and lipid metabolism (11%) (Fig.
6B; Additional file 3: Supplemental Table S3). These
results are similar to that observed for the ‘differentiation-
associated’ data set (Fig. 1; Additional file 3: Supplemental
Table S3). Not all ‘differentiation-associated’ genes are
regulated by PI3K suggesting that other signaling pathways
contribute to the regulation of trophoblast differentiation.
A subset of the ‘positively regulated’ PI3K-dependent
genes identified from the microarray analysis was further
evaluated by northern analysis or qRT-PCR in Rcho-1
trophoblast cells treated with the PI3K inhibitor or vehicle
(Fig. 6C, D). The ‘differentiation-associated’ genes sensitive
to PI3K regulation have potential roles in cell invasion (e.
g. Igf2, Mmp9, Serpine1), immune and vascular cell regula-
tion (e.g. Adm, Cgm4, Ceacam 3, Ceacam10, Prl4a1, Il17f,
Ctsd, Faslg, Sema6d), and the endocrine phenotype of tro-
phoblast giant cells (e.g. Prl3b1, Prl4a1, Cyp17a1). In an
additional experiment, we sought to determine whether
the effects of the PI3K inhibitor on trophoblast gene
expression required exposure throughout the differentia-
tion process or whether the inhibitor could act acutely to
affect differentiated trophoblast cell function. Several of
the ‘differentiation-associated’ genes were also sensitive to
acute disruption of the PI3K signaling pathway (Fig. 7).
PI3K regulation of trophoblast steroidogenesis
Trophoblast giant cells are known sites for the biosynth-
esis of progesterone and androstenedione [12,21]. Sev-
eral genes encoding proteins involved in the
biosynthesis of steroid hormones are upregulated during
trophoblast differentiation (Additional file 4: Table S4;
Fig. 8). These include Star, which encodes a protein
involved in transporting cholesterol to the mitochondria,
and a series of genes encoding enzymes responsible for
the production of progesterone and androstenedione
(Cyp11a1, Hsd3b1, Cyp17a1, Hsd17b2;F i g .8 A ) .Hsd3b1
and Cyp17a1 expression were positively regulated by
PI3K signaling (Fig. 8B). Consistent with this
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Figure 2 Expression of a subset of ‘trophoblast stem cell-associated’ genes. A) Representative northern blot analysis of ‘trophoblast stem
cell-associated’ genes identified by DNA microarray analysis. B) qRT-PCR analysis of ‘trophoblast stem cell-associated’ genes identified by DNA
microarray analysis. See Table 1 for a list and description of the mRNAs investigated. Rcho-1 trophoblast stem cells were cultured under stem (S)
or differentiating (D) conditions. Rat placental samples were also included in the analysis and are from gestation d11.5 trophoblast and d18.5
junctional zone. Student’s t-tests (*P < 0.05).
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Page 7 of 18Table 2 Trophoblast differentiation associated genes
Gene name Abbreviation Synonyms Functional Group GenBank
Accession No.
Fold
Change
D/S
Fold
Change D/D
+LY
Keratin complex 1, acidic, gene 19 Krt19 EndoC, K19 Cytoskeletal protein NM_199498 149.07
t -
Carcinoembryonic antigen gene family 4 Cgm4 Psg16,
Psg38
Secretory protein,
unknown function
NM_012525 89.73 -2.79
Carcinoembryonic antigen-related cell adhesion
molecule 3
Ceacam3 Cgm1 Cell adhesion
molecule
NM_012702 88.71 -1.75
Cytochrome P450, family 11, subfamily a,
polypeptide 1
Cyp11a1 P450scc Steroidogenic enzyme NM_017286 47.11 -
Prolactin family 4, subfamily a, member 1 Prl4a1 PLP-A Ligand/cytokine NM_017036 33.05 -3.91
Spleen protein 1 precursor Rsp1 Sslp1,
LOC171573
Unknown NM_138537 30.29 -4.43
Solute carrier family 28 (sodium-coupled
nucleoside transporter), member 2
Slc28a2 Cnt2 Transporter,
nucleotide
NM_031664 23.94 -1.71
Interleukin 17F Il17f ML1 Ligand/cytokine NM_001015011 22.49 -2.61
Fibronectin 1 Fn1 Fn Extracellular matrix
protein
NM_019143 19.68 -
H19 fetal liver mRNA H19 ASM1 Unknown NR_027324 13.10 -
Cytochrome P450, family 17, subfamily a,
polypeptide 1
Cyp17a1 Cyp17,
p450c17
Steroidogenic enzyme NM_012753 10.76 -4.57
Hydroxysteroid (17-beta) dehydrogenase 2 Hsd17b2 Steroidogenic enzyme NM_024391 10.56 –
Placenta-specific 1 Plac1 Epcs26 Cell-cell comunication NM_001024894 9.62 –
CEA-related cell adhesion molecule 10 Ceacam10 C-CAM4 Cell adhesion
molecule
NM_173339 8.66 -1.86
Differentaly expressed X chromosome EST 1 Dif EST 1 AI012949 8.61 –
Prolactin family 3, subfamily b, member 1 Prl3b1 PL-II, Csh2 Ligand/cytokine NM_012535 8.38 -7.73
CD47 antigen (Rh-related antigen, integrin-
associated signal transducer)
Cd47 IAP, Itgp Receptor,
thrombospondin
NM_019195 7.90 -
Sema domain, transmembrane domain (TM), and
cytoplasmic domain, (semaphorin) 6D
Sema6d Receptor NM_001107768 8.38 -1.56
Differentaly expressed X chromosom EST 2 Dif EST 2 LOC681066 AA964255 7.40 -
Serine (or cysteine) peptidase inhibitor, clade E,
member 1
Serpine1 Pai1, Planh blood coagulation,
angiogenesis
NM_012620 6.41 -3.95*
Extracellular matrix protein 1 Ecm1 Extracellular protein NM_053882 6.11 -
Adrenomedullin Adm Hypotensive peptide NM_012715 5.81 -14.40
Moesin Msn Cell-cell comunication NM_030863 5.66 -
DNA-damage inducible transcript 3 Ddit3 Chop10,
Gadd153
Cell stress/death NM_001109986 5.65 -1.86
Melanoma antigen, family D, 1 Maged1 Nrage,
Dlxin1
Apoptosis, cell cycle,
transcription
NM_053409 5.61 -
Cbp/p300-interacting transactivator, with Glu/Asp-
rich carboxy-terminal domain, 2
Cited2 Mrg1,
Msg2,
p35srj
Transcription
regulator
NM_053698 5.49 -
Hydroxy-delta-5-steroid dehydrogenase, 3 beta-
and steroid delta-isomerase 1
Hsd3b1 Steroidogenic enzyme NM_001007719 5.15 -
Fos-like antigen 1 Fosl1 Fra1 Transcription
regulator
NM_012953 5.04 -
Legumain Lgmn Prsc1 Putative cysteine
protease
NM_022226 4.73 -
Insulin-like growth factor 2 Igf2 Igf-II Ligand, growth factor NM_031511 4.38 -3.74
Tribbles homolog 3 (Drosophila) Trib3 Trb3, Ifld2,
Nipk
Metabolism NM_144755 4.37 -2.09
High mobility group box transcription factor 1 Hbp1 HMGB1 Transcription
regulator
NM_013221 4.36 -
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Page 8 of 18observation, the production of androstenedione by dif-
ferentiating trophoblast cells was also dependent upon
PI3K (Fig. 8C).
Discussion
Organization of the hemochorial placenta is the result of
signaling pathways directing the expansion and differen-
tiation of trophoblast stem cell and progenitor cell
populations. This decision-making culminates in the sys-
tematic activation and inactivation of gene networks
within trophoblast cell populations and elaboration of
specific functions that facilitate redirection of resources
from the mother to the fetus. In this report, we utilized
the Rcho-1 trophoblast stem cell model and induced dif-
ferentiation through increased cell density and removal
of growth stimuli. The growth factor deprivation may
also lead to activation of stress pathways, which have
been shown to influence trophoblast differentiation [22].
Using this strategy, we have identified genes associated
with trophoblast stem cell expansion, differentiation,
and those impacted by the PI3K signaling pathway.
Trophoblast stem cell-associated genes
Stem cells possess the potential to proliferate and to dif-
ferentiate. Several genes implicated in maintenance of
the trophoblast stem cell state were identified in Rcho-1
trophoblast stem cells and are similarly present in
mouse trophoblast stem cells. These include an assort-
ment of genes implicated as cell cycle regulators in
numerous cell types and also genes that have been more
specifically shown to have a role in the specification and
maintenance of trophoblast stem cells (e.g. Cdx2, Eomes,
Id1, Id2) [23-25].
Phlda2 displayed one of the most striking differences in
its expression profile in stem versus differentiated cells. It
was high in stem cells and virtually undetectable follow-
ing differentiation, which is also found in mouse tropho-
blast stem cells. Phlda2 is intriguing for a number of
reasons. Phlda2 is an imprinted gene exhibiting maternal
allele-specific expression in extraembryonic and embryo-
nic structures and in postnatal tissues, including the kid-
ney [26,27]. In the mouse, disruption of the Phlda2 gene
leads to placental overgrowth, while overexpression of
Phlda2 results in placental growth restriction [28-30].
Given that PHLDA2 restrains placental growth it seems
counter-intuitive that it would be abundantly expressed
in stem cell populations. Insights will likely be forthcom-
ing when more is learned about the cellular actions of
PHLDA2. The activities of PHLDA2 may be linked to its
pleckstrin homology domain and ability to bind phos-
phoinositides and could include an intracellular signal
transduction function [31].
Table 2 Trophoblast differentiation associated genes (Continued)
Cathepsin D Ctsd CD, CatD Lysosomal aspartic
endopeptidase
NM_134334 4.13 -3.00
Matrix metallopeptidase 9 Mmp9 Gelatinase
B
Extracellular matrix
remodeling
NM_031055 4.00 -3.11
Fas ligand (TNF superfamily, member 6) Faslg Faslg,
Tnfsf6
Ligand/membrane
anchored
NM_012908 3.80 -3.06
Reproductive homeobox on X chromosome, 9 Rhox9 Gpbox,
Psx2
Transcription
regulator
NM_001024874 3.43 -
Granulin Grn Gep, Pcdgf,
Pgrn
Ligand, growth factor NM_017113 3.39 -
CD9 antigen Cd9 Tspan29 Cell surface
glycoprotein
NM_053018 3.14 -
RhoB gene Rhob Arhb Ras family NM_022542 3.07 2.08*
Phosphatidylinositol 3-kinase, catalytic, beta
polypeptide
Pik3cb Inositol lipid kinase NM_053481 2.75 -
Kruppel-like factor 2 (lung) Klf2 Transcription
regulator
NM_001007684 2.73 4.70
Jun-B oncogene Junb Transcription
regulator
NM_021836 2.35 -
Tissue factor pathway inhibitor Tfpi EPI, LACI Kunitz family serine
protease inhibitor
NM_017200 2.20 -
Nuclear factor, erythroid derived 2, like 2 Nfe2l2 Nrf2 Transcription
regulator
NM_031789 2.09 -
S/D: Stem cell state/differentiation cell state ratio
D/D+LY: Differentiation cell state/differentiation cell state + LY294002 treatment
* Fold change values based on qRT-PCR analysis
t Not significant by student t-test
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Figure 3 Expression of a subset of trophoblast ‘differentiation-associated’ genes. A) Representative northern blot analysis of trophoblast
‘differentiation-associated’ genes identified by DNA microarray analysis. B) qRT-PCR analysis of trophoblast ‘differentiation-associated’ genes
identified by DNA microarray analysis. See Table 2 for a list and description of the mRNAs investigated. Rcho-1 trophoblast stem cells were
cultured under stem (S) or differentiating (D) conditions. Rat placental samples were also included in the analysis and are from gestation d11.5
trophoblast and d18.5 junctional zone. Student’s t-tests (*P < 0.05).
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Page 10 of 18Figure 4 ’Differentiation-associated’ genes are expressed by trophoblast cells developing within the chorioallantoic placenta. In situ
detection of mRNA expression of ‘differentiation-associated’ genes in gestational d11.5 and d18.5 rat placentation sites is presented. Bars = 1
mm. Left panels, d11.5 placentation sites, far left: low magnification; middle left: high magnification of boxed area. Right panels, d18.5
placentation sites, middle right: low magnification; far right: high magnification of boxed area. Red arrowheads, trophoblast giant cells; red
arrows, invasive trophoblast giant cells; yellow arrows, spongiotrophoblast; green arrowheads, endovascular invasive trophoblast; green arrows,
interstitial invasive trophoblast.
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blast stem cells and Rcho-1 trophoblast stem cells are
noteworthy. Elf5, a member of the ETS transcription
factor family and a player in the derivation and main-
tenance of mouse trophoblast stem cells [32-34] is not
among the ‘trophoblast stem cell-associated’ genes of
the Rcho-1 trophoblast stem cell model. This may
relate to differences in the requirements for exogenous
factors to maintain trophoblast stem cell populations.
Mouse trophoblast stem cells are dependent upon
fibroblast growth factor-4 (FGF4)/FGF receptor 2 sig-
naling [35], whereas maintenance of Rcho-1 tropho-
blast stem cells does not require FGF4 [10]. Evidence
indicates that ELF5 may be a downstream effector of
FGF4 signaling needed to sustain activation of Cdx2
and Eomes genes and the trophoblast stem cell state
[33]. The requirement for Elf5 must in some way be
circumvented in Rcho-1 trophoblast stem cell
maintenance. In addition to Rcho-1 trophoblast stem
cells other recently derived trophoblast cell lines from
the rat and common vole also grow in the absence of
exogenous FGF4 [36,37]. These observations do not
reflect a fundamental species difference in the regula-
tion of trophoblast stem cells. FGF4-dependent tropho-
blast stem cell lines can be established from the rat
blastocyst (K. Asanoma and M.J. Soares, unpublished
data). Instead, the FGF4 independence of the tropho-
blast stem cell populations is probably the conse-
quence of genetic and/or epigenetic modifications and
in vitro selection.
Several ‘trophoblast stem cell-associated genes’ were
not shared with mouse trophoblast stem cells. Among
these genes were Mif and S1pr1. Mif encodes a pro-
inflammatory cytokine implicated in the regulation of
angiogenesis [38], the migration and adhesion of
monocytes [39], and modulation of uterine natural
Figure 5 PI3K impact on trophoblast cell differentiation: morphology and DNA content. Morphology and DNA content were assessed in
Rcho-1 trophoblast stem cells cultured in the following conditions: stem (Stem), differentiating (Dif), differentiating with vehicle exposure (0.1%
DMSO; Dif+V), or LY294002 (10 μM; Dif+LY). A) Morphology was determined by bright field microscopy (top panels). Actin filaments were
stained with rhodamine-conjugated phalloidin; nuclei were visualized with DAPI (bottom). Bar= 50 μm. B) DNA content was estimated by
propidium iodine staining followed by flow cytometry. Due to the tetraploid nature of the Rcho-1 trophoblast cells, 4N and 8N cell populations
correspond to dividing cells, whereas cell populations with more than 8N DNA content have undergone endoreduplication. C) Graphic
representation of three independent flow cytometry experiments. Student’s t-tests (*P < 0.05).
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Page 12 of 18killer cell cytolytic activity [40]. S1pr1 encodes a Gi
protein-coupled receptor for sphingosine 1-phosphate
(S1P). S1P has been implicated in a range of functions,
including controlling cell proliferation and differentia-
tion [41]. In human trophoblast, S1P inhibits differen-
tiation [42]. Activation of some of the ‘trophoblast
stem cell-associated’ genes may represent a develop-
mental progression beyond the trophoblast stem cell
state exhibited by mouse trophoblast stem cells or
alternatively may provide Rcho-1 cells with their
tumorigenic features [18,43].
Trophoblast differentiation-associated genes
’Differentiation-associated’ genes possess a broader
range of functions than noted for the ‘trophoblast stem
cell-associated’ gene cluster. Many of these genes are
characteristic of the trophoblast giant cell phenotype.
The trophoblast giant cell is conspicuous in its location
at the maternal-fetal interface and its functions are in
large part directed toward uterine structures and in
facilitating maternal adaptations to pregnancy. These
functions include endocrine activities (PRL family and
steroidogenesis) and intrauterine invasion and
Figure 6 PI3K regulation: Analysis of microarray data and expression of a subset of PI3K regulated genes. A) Scatter graph showing the
signal intensity of probe sets. B) Functional analysis of negatively and positively regulated genes by PI3K using Ingenuity Pathway Analysis
software. C) Representative northern blot analyses of genes regulated by PI3K originally identified by DNA microarray analysis. D) qRT-PCR
analysis of genes regulated by PI3K originally identified by DNA microarray analysis. See Tables 1 and 2 for a list and description of the mRNAs
investigated. Rcho-1 trophoblast stem cells were cultured under differentiating conditions with exposure to vehicle (0.1% DMSO; D+V) or
LY294002 (10 μM; D+LY). Student’s t-tests (*P < 0.05).
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Page 13 of 18modulation of the maternal vasculature and immune
cells (Il17f, Tfpi, Cgm4, Ecm1, Cd47, Fn, Lgmn, Mmp9,
Grn, Igf2).
Among the ‘differentiation-associated’ genes was a
subgroup of genes encoding transcriptional regulators
(H b p 1 ,D d i t 3 ,R h o x 9 ,N r f 2 ,F o s l 1 ,J u n b ,C i t e d 2 ). Mouse
mutagenesis experimentation has implicated a few of
these genes (Fosl1, Junb, Cited2) as regulators of placen-
tal development [44-46]. However, the specific roles of
FOSL1, JUNB. CITED2, and the other transcriptional
regulators in the regulation of trophoblast differentiation
are yet to be determined. Some may participate in the
regulation or maintenance of the differentiated tropho-
blast cell phenotype.
There is a connection between the ‘differentiation-
associated’ genes and the PI3K/AKT signaling pathway.
As trophoblast stem cells differentiate, the PI3K/AKT
signaling pathway becomes constitutively activated [7].
IGF2 and GRN are candidate autocrine activators of the
PI3K/AKT signaling pathway [47,48]. Trb3 and Msn
were also classified as ‘differentiation-associated’ genes.
They encode proteins with potential roles downstream
of PI3K/AKT signaling pathway [49,50].
PI3K signaling-sensitive genes
PI3K regulates the phenotype of differentiating tropho-
blast cells [7]. Endoreduplication and/or survival of tro-
phoblast giant cells are influenced by PI3K signaling. An
active PI3K pathway favors trophoblast giant cells with
lower ploidy levels. These cells may be more motile and
phenotypically resemble midgestation trophoblast lining
uterine spiral arteries [51]. PI3K signaling also possesses
dramatic effects on gene expression patterns.
Overall, the functions of the PI3K-sensitive genes are
biologically less diverse. Most interestingly, they include
genes encoding proteins potentially impacting tropho-
blast invasion (Mmp9, [52]; Igf2,[ 5 3 - 5 5 ] ;Serpine1,
[56-58]), directed to the maternal uterine environment
Figure 7 Acute inhibition of PI3K is sufficient to regulate expression of PI3K sensitive genes. qRT-PCR analysis of trophoblast ‘differentiation-
associated’ genes regulated by PI3K under acute PI3K inhibition. Rcho-1 trophoblast stem cells were cultured under differentiating conditions for
6 days and for an additional 48 h of treatment with vehicle (0.1% DMSO; D+V) or LY294002 (10 μM; D+LY). Student’s t-tests (*P < 0.05).
Kent et al. BMC Developmental Biology 2010, 10:97
http://www.biomedcentral.com/1471-213X/10/97
Page 14 of 18influencing immune and vascular cells (Cgm4, Faslg,
P r l 4 a 1 ,A d m ,I l 1 7 f ), and also regulating androgen bio-
synthesis (Hsd3b1, Cyp17a1).
Cgm4 is one of the most abundant genes expressed by
differentiating trophoblast cells. It encodes a member of
the expanded pregnancy specific glycoprotein (PSG)
family called PSG16. PSGs act on immune cells, poten-
tially through CD9, to influence cytokine production
[59-62]; they also target the vasculature and modulate
endothelial cell function [63]. The presence of Cd9 in
differentiating trophoblast cells implies that PSGs may
also possess autocrine/paracrine actions on trophoblast
development, which may include regulating the tropho-
blast invasive phenotype [63].
FAS ligand (FASLG), PRL-like protein A (PLP-A;
Prl4a1), adrenomedullin (ADM), and interleukin 17f
(IL17F) are cytokines produced by differentiating tro-
phoblast that are exquisitely sensitive to PI3K regulation.
FASLG binds to the FAS receptor and can initiate cell
death. Trophoblast derived FASLG has been implicated
as a modulator of intraplacental immune cell trafficking
[64,65] and is hypothesized to be a key participant in
uterine spiral arteriole remodeling [66,67]. PLP-A targets
natural killer cells and contributes to placentation site-
specific adaptations to physiological stressors [3,68,69].
ADM may possess an autocrine role regulating tropho-
blast invasion [70] but also probably affects the uterine
vasculature by regulating vessel diameter, permeability,
and angiogenesis [71-73]. Insights about IL17F and its
potential role at the placentation site are limited. IL17F
is proinflammatory with prominent effects on immune
and vascular cells [74-76]. Whether IL17F contributes to
the organization of the hemochorial placentation site
remains to be determined.
Key components of the enzymatic machinery required
for trophoblast cell androgen biosynthesis are positively
regulated by PI3K, including 17a hydroxylase (encoded
by Cyp17a1). Trophoblast giant cells are sites of andros-
tenedione biosynthesis [77,78]. Androstenedione can
serve as a prohormone for the biosynthesis of estrogens
and more potent androgens, such as testosterone. Estro-
gens possess a vital luteotropic role essential for the
maintenance of pregnancy [78]. Differentiating rodent
trophoblast cells also express 17b hydroxysteroid dehy-
drogenase type 2 (encoded by Hsd17b2), which is
responsible for converting testosterone to less biologi-
cally potent androgens, thereby protecting the fetus
from excessive androgen exposure [79,80]. Thus, PI3K
signaling has a vital role in determining the steroid hor-
mone milieu at the maternal-fetal interface.
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Figure 8 PI3K regulates steroidogenic potential of trophoblast cells. A) Overview of the steroidogenic pathway in trophoblast giant cells. B)
Representative northern blot analysis of genes encoding components of the steroidogenic pathway in Rcho-1 trophoblast cells. Rcho-1
trophoblast cells were cultured under stem (S), differentiating (D) and differentiating with chronic or acute exposure to LY294002 (10 μM; D+LY)
or vehicle (0.1% DMSO; D+V) conditions. C) Progesterone and androstenedione concentrations were measured by RIA in conditioned medium
from Rcho-1 trophoblast stem cells cultured in differentiating conditions with chronic or acute exposure to LY294002 (10 μM D+LY) or vehicle
(0.1% DMSO; D+V). Acute conditions consisted of 12 days of differentiation and an additional 48 h of treatment with vehicle or LY294002
treatment. Steroid measurements were normalized to DNA content. Student’s t-tests (*P < 0.05).
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In summary, the PI3K signaling pathway regulates the
differentiated trophoblast cell phenotype. Under the
direction of the PI3K signaling pathway, trophoblast
cells produce a battery of cytokines and hormones.
These extracellular signals modulate intrauterine
immune and inflammatory cells, regulate vascular remo-
deling, and collectively ensure a successful pregnancy.
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